Epigenomic Alterations in Breast Carcinoma from Primary Tumor to Locoregional Recurrences

• Matahi Moarii,

  Affiliations Centre for Computational Biology, Mines ParisTech, Fontainebleau, France, Institut Curie, Paris, France, U900, INSERM, Paris, France

  ⨯
• Alice Pinheiro,

  Affiliations UMR144, Oncology Molecular Team, Institut Curie, Paris, France, Department of translational research, Residual Tumor and Response to Treatment Team, Institut Curie, Paris, France

  ⨯
• Brigitte Sigal-Zafrani,

  Affiliation Department of Tumor Biology, Institut Curie, Paris, France

  ⨯
• Alain Fourquet,

  Affiliation Department of Radiotherapy, Institut Curie, Paris, France

  ⨯
• Martial Caly,

  Affiliation Department of Tumor Biology, Institut Curie, Paris, France

  ⨯
• Nicolas Servant,

  Affiliations Centre for Computational Biology, Mines ParisTech, Fontainebleau, France, Institut Curie, Paris, France, U900, INSERM, Paris, France

  ⨯
• Véronique Stoven,

  Affiliations Centre for Computational Biology, Mines ParisTech, Fontainebleau, France, Institut Curie, Paris, France, U900, INSERM, Paris, France

  ⨯
• Jean-Philippe Vert,

  Affiliations Centre for Computational Biology, Mines ParisTech, Fontainebleau, France, Institut Curie, Paris, France, U900, INSERM, Paris, France

  ⨯
• Fabien Reyal

  * E-mail: fabien.reyal@curie.fr

  Affiliations UMR144, Oncology Molecular Team, Institut Curie, Paris, France, Department of translational research, Residual Tumor and Response to Treatment Team, Institut Curie, Paris, France, Department of Surgery, Institut Curie, Paris, France

  ⨯